J&J explores bid for Intra-Cellular Therapies, Bloomberg News reports
Jan 12 (Reuters) - Johnson & Johnson JNJ.N is exploring a bid to acquire Intra-Cellular Therapies Inc ITCI.O , a biopharmaceutical company, Bloomberg News reported on Sunday citing people familiar with the matter. (Reporting by Angela Christy in Bengaluru; Editing by Sandra Maler) ((AngelaChristy.M@thomsonreuters.com;))
Recent news on Intra-Cellular Therapies
See all newsBrief: Intra-Cellular Therapies stockholder filed lawsuit against co, board in NY Supreme Court
Intra-Cellular Therapies Inc reports results for the quarter ended December 31 - Earnings Summary
U.S. RESEARCH ROUNDUP-Apple, Caterpillar, Visa
Street View: New drug launches, ITCI deal to boost J&J's growth
J&J beats quarterly sales and profit estimates on cancer drug sales (updated)